human interleukin 4 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
96
Structured Review
R&D Systems
human interleukin 4
Human Interleukin 4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1026 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+interleukin+4/Recombinant+Human+IL-4+Protein/pmc13093023-45-54-61
Average 96 stars, based on 1026 article reviews
Human Interleukin 4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1026 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+interleukin+4/Recombinant+Human+IL-4+Protein/pmc13093023-45-54-61
Average 96 stars, based on 1026 article reviews
human interleukin 4 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Cell Culture:Article Title: Differential Production of Midkine and Pleiotrophin by Innate APCs upon Stimulation through Nucleic Acid-Sensing TLRs Article Snippet: Macrophages were differentiated from monocytes cultured under adherence conditions for 6 days in RPMI media (Gibco, UK) supplemented with 50 ng/ml human recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF; R&D, UK). .. MDDCs were obtained from monocytes cultured under adherence conditions for 6 days in RPMI media supplemented with 50 ng/ml of human Article Title: Functional characterization of biodegradable nanoparticles as antigen delivery system Article Snippet: .. Briefly, isolated PBMCs were allowed to adhere to plastic in 6-well plates for 2 h. Adherent monocytes were washed with RPMI 1640 medium and were then cultured for 6 days in DC culture medium supplemented with 50 ng of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF; R&D Systems, Minneapolis, Minn.) per mL and 1000 U of Recombinant:Article Title: Differential Production of Midkine and Pleiotrophin by Innate APCs upon Stimulation through Nucleic Acid-Sensing TLRs Article Snippet: Macrophages were differentiated from monocytes cultured under adherence conditions for 6 days in RPMI media (Gibco, UK) supplemented with 50 ng/ml human recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF; R&D, UK). .. MDDCs were obtained from monocytes cultured under adherence conditions for 6 days in RPMI media supplemented with 50 ng/ml of human Article Title: A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3 Article Snippet: .. Autologous dendritic cells were established by growing monocytes in the presence of granulocyte monocyte-colony stimulating factor (50 ng/mL, Sanofi-Aventis, #420039) and Article Title: Functional characterization of biodegradable nanoparticles as antigen delivery system Article Snippet: .. Briefly, isolated PBMCs were allowed to adhere to plastic in 6-well plates for 2 h. Adherent monocytes were washed with RPMI 1640 medium and were then cultured for 6 days in DC culture medium supplemented with 50 ng of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF; R&D Systems, Minneapolis, Minn.) per mL and 1000 U of Article Title: MAP4-regulated dynein-dependent trafficking of BTN3A1 controls the TBK1–IRF3 signaling axis Article Snippet: Monocytes were isolated from PBMCs using a magnetic bead-based positive-selection kit (IMag) and an anti-human CD14 antibody (BD Biosciences). .. To generate monocyte-derived macrophages (MDMs), CD14-positive cells were treated with human Article Title: A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence Article Snippet: .. Autologous dendritic cells were established by growing monocytes in the presence of granulocyte monocyte-colony stimulating factor (50 ng/mL, Sanofi-Aventis, Paris, France) and Article Title: A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3 Article Snippet: .. Autologous dendritic cells were established by growing monocytes in the presence of granulocyte monocyte-colony stimulating factor (50 ng/mL, Sanofi-Aventis, #420039) and Article Title: Human macrophages and monocyte-derived dendritic cells stimulate the proliferation of endothelial cells through midkine production Article Snippet: Macrophages were obtained from monocytes cultured for 6 days in RPMI media (Gibco, UK) supplemented with 50 ng/ml human recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF; R&D, UK). .. MDDCs were differentiated from monocytes for 6 days in RPMI media supplemented with 50 ng/ml GM-CSF and 50 ng/ml of human Irradiation:Article Title: A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3 Article Snippet: .. Autologous dendritic cells were established by growing monocytes in the presence of granulocyte monocyte-colony stimulating factor (50 ng/mL, Sanofi-Aventis, #420039) and Article Title: A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence Article Snippet: .. Autologous dendritic cells were established by growing monocytes in the presence of granulocyte monocyte-colony stimulating factor (50 ng/mL, Sanofi-Aventis, Paris, France) and Article Title: A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3 Article Snippet: .. Autologous dendritic cells were established by growing monocytes in the presence of granulocyte monocyte-colony stimulating factor (50 ng/mL, Sanofi-Aventis, #420039) and Expressing:Article Title: A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3 Article Snippet: .. Autologous dendritic cells were established by growing monocytes in the presence of granulocyte monocyte-colony stimulating factor (50 ng/mL, Sanofi-Aventis, #420039) and Article Title: A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence Article Snippet: .. Autologous dendritic cells were established by growing monocytes in the presence of granulocyte monocyte-colony stimulating factor (50 ng/mL, Sanofi-Aventis, Paris, France) and Article Title: A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3 Article Snippet: .. Autologous dendritic cells were established by growing monocytes in the presence of granulocyte monocyte-colony stimulating factor (50 ng/mL, Sanofi-Aventis, #420039) and Isolation:Article Title: Functional characterization of biodegradable nanoparticles as antigen delivery system Article Snippet: .. Briefly, isolated PBMCs were allowed to adhere to plastic in 6-well plates for 2 h. Adherent monocytes were washed with RPMI 1640 medium and were then cultured for 6 days in DC culture medium supplemented with 50 ng of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF; R&D Systems, Minneapolis, Minn.) per mL and 1000 U of |